Polycystic ovarian syndrome and insulin resistance

Clinics in Family Practice

Volumn 4, Issue 3, 2002, Pages 623-626

  McFarlane, Keri J ^a   Isé, Charleen ^a   Linton, Candy ^a  

^a Family Study Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ESTROGEN; HYDROXYPROGESTERONE; INSULIN; INSULIN RECEPTOR;

ANDROGEN BLOOD LEVEL; ANDROGEN SYNTHESIS; ARTICLE; AUTOPHOSPHORYLATION; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; DIABETES MELLITUS; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; ESTROGEN SYNTHESIS; FEEDBACK SYSTEM; FEMALE; HORMONAL REGULATION; HUMAN; HYPERANDROGENISM; HYPOTHESIS; INSULIN RESISTANCE; INSULIN SENSITIVITY; OVARY INSUFFICIENCY; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; RECEPTOR DOWN REGULATION; RISK FACTOR;

EID: 0036764004     PISSN: 15225720     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1522-5720(02)00038-7     Document Type: Article

References (5)

1. Carmina, E, Rogerio L. Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab 1999;84:1897-99.
2. Legro, R. Diabetes prevalence and risk factors in polycystic ovary syndrome. Obstet Gynecol Clin 2001;28:99-109.
3. Taylor A. Gonadal disorders polycystic ovary syndrome. Endocrinol Metab Clin 1998;27:877-96.
4. Bachmann G. Polycystic ovary syndrome: metabolic challenges and new treatment options. Am J Obstet Gynecol 1998;179:S87-88.
5. Guzick D. Polycystic ovary syndrome: symptomatology, pathophysiology, and epidemiology. Am J Obstet Gynecol 1998;179:S89-93.1998;179:S89-93.